C90.20
Extramedullary plasmacytoma not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Extramedullary plasmacytoma with failed remission
- Extramedullary plasmacytoma NOS
Medical Intelligence & Overview
Extramedullary plasmacytoma is a rare type of plasma cell tumor that occurs outside the bone marrow, typically in soft tissues. When this condition is classified as not having achieved remission, it indicates that the cancer persists or has recurred despite treatment efforts. This diagnosis, coded as ICD-10 C90.20, reflects ongoing disease activity, highlighting the importance of continuous medical evaluation and management.
Causes & Symptoms
Clinical Causes: The exact cause of extramedullary plasmacytoma is unknown, but it involves abnormal growth of plasma cells in soft tissue sites. Genetic mutations and immune system factors may contribute to the development of the tumor. Previous treatment failure or incomplete response to therapy can result in persistent disease. In some cases, extramedullary plasmacytoma may develop as part of multiple myeloma or other plasma cell disorders.
Key Symptoms: Lumps or masses in soft tissue areas such as the head, neck, or gastrointestinal tract. Unexplained swelling or pain in the affected region. Localized neurological symptoms if the tumor compresses nerves or spinal cord. Other systemic signs like fatigue or weight loss in cases related to broader plasma cell disorders.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, imaging tests (such as MRI or CT scans), and tissue biopsy. The biopsy confirms the presence of abnormal plasma cells in the soft tissue. Blood and urine tests may be performed to check for abnormal proteins associated with plasma cell disorders. Since the disease has not achieved remission, ongoing assessments are necessary to monitor tumor activity and response to treatments.
Treatment Protocols: Treating extramedullary plasmacytoma that has not achieved remission often involves a multidisciplinary approach. Options may include radiation therapy to target localized tumors, systemic chemotherapy to control widespread disease, or targeted therapies depending on the specific case. Clinical trials may also be considered for advanced or refractory cases. Management focuses on controlling tumor growth, alleviating symptoms, and improving quality of life, with regular follow-up to assess treatment efficacy.
Clinical Advice & FAQs
Billing Guidance
Is C90.20 a billable ICD-10 code?
Yes, C90.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C90.20?
Clinical documentation must specify the nature of Extramedullary plasmacytoma not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference